BrYet US

BrYet is a privately-owned biotech company dedicated to discovering and developing first-in-class therapies for primary and metastatic cancers, particularly those affecting the lungs and liver. The company aims to create fully curative approaches to metastatic cancer through innovative multi-component therapeutics targeting transport phenotypes. Th... eir research has shown unprecedented efficacy in preclinical trials and is supported by a robust patent portfolio. BrYet's intended clients include patients suffering from otherwise incurable cancers, as well as the broader medical community seeking advanced treatment options.Read More